H Brandone

2.7k total citations
33 papers, 2.1k citations indexed

About

H Brandone is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, H Brandone has authored 33 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cancer Research, 15 papers in Pathology and Forensic Medicine and 15 papers in Oncology. Recurrent topics in H Brandone's work include Breast Cancer Treatment Studies (25 papers), Breast Lesions and Carcinomas (13 papers) and Cancer Treatment and Pharmacology (5 papers). H Brandone is often cited by papers focused on Breast Cancer Treatment Studies (25 papers), Breast Lesions and Carcinomas (13 papers) and Cancer Treatment and Pharmacology (5 papers). H Brandone collaborates with scholars based in France, Switzerland and United States. H Brandone's co-authors include Y Aymé, J M Spitalier, R. Amalric, C Bressac, Daniel Hans, John M. Kurtz, Jocelyne Jacquemier, R Amalric, Jocelyne Jacquemier and Julia Kurtz and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Surgery.

In The Last Decade

H Brandone

32 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Brandone France 19 1.9k 1.3k 851 588 259 33 2.1k
Y Aymé France 19 1.8k 1.0× 1.3k 1.0× 840 1.0× 612 1.0× 249 1.0× 34 2.1k
R. Amalric France 17 1.8k 0.9× 1.3k 1.0× 831 1.0× 503 0.9× 249 1.0× 38 2.1k
J M Spitalier France 17 1.7k 0.9× 1.2k 0.9× 761 0.9× 511 0.9× 230 0.9× 24 1.9k
J.C. Durand France 18 1.5k 0.8× 1.1k 0.8× 972 1.1× 548 0.9× 216 0.8× 30 2.2k
S J Schnitt United States 17 1.6k 0.8× 1.1k 0.9× 816 1.0× 445 0.8× 322 1.2× 33 2.1k
Bernard S. Lewinsky United States 19 2.1k 1.1× 1.8k 1.4× 879 1.0× 717 1.2× 184 0.7× 31 2.8k
Jeffrey R. Harris United States 13 1.0k 0.5× 717 0.6× 523 0.6× 332 0.6× 156 0.6× 23 1.3k
Sharon Galper United States 8 1.4k 0.7× 1.1k 0.8× 562 0.7× 729 1.2× 81 0.3× 8 1.7k
Parvis Gamagami Switzerland 19 2.3k 1.2× 1.9k 1.4× 875 1.0× 917 1.6× 167 0.6× 31 2.7k
J.R. Vilcoq France 13 1.1k 0.6× 668 0.5× 720 0.8× 297 0.5× 176 0.7× 22 1.4k

Countries citing papers authored by H Brandone

Since Specialization
Citations

This map shows the geographic impact of H Brandone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Brandone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Brandone more than expected).

Fields of papers citing papers by H Brandone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Brandone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Brandone. The network helps show where H Brandone may publish in the future.

Co-authorship network of co-authors of H Brandone

This figure shows the co-authorship network connecting the top 25 collaborators of H Brandone. A scholar is included among the top collaborators of H Brandone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Brandone. H Brandone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amalric, R, et al.. (1998). Résultats du traitement par chirurgie conservatrice et irradiation de 132 carcinomes canalaires in situ non palpables du sein. Cancer/Radiothérapie. 2(1). 19–26. 3 indexed citations
2.
Kurtz, John M., Jocelyne Jacquemier, R Amalric, et al.. (1991). Is breast conservation after local recurrence feasible?. European Journal of Cancer and Clinical Oncology. 27(3). 240–244. 86 indexed citations
3.
Kurtz, John M., R. Amalric, H Brandone, Y Aymé, & J M Spitalier. (1991). How important is adequate radiotherapy for the long-term results of breast-conserving treatment?. Radiotherapy and Oncology. 20(2). 84–90. 18 indexed citations
4.
Kurtz, Julia, Jocelyne Jacquemier, R. Amalric, et al.. (1990). Why are local recurrences after breast-conserving therapy more frequent in younger patients?. Journal of Clinical Oncology. 8(4). 591–598. 205 indexed citations
5.
Kurtz, John M., J M Spitalier, R. Amalric, et al.. (1990). The prognostic significance of late local recurrence after breast-conserving therapy. International Journal of Radiation Oncology*Biology*Physics. 18(1). 87–93. 145 indexed citations
6.
Kurtz, John M., Jocelyne Jacquemier, R. Amalric, et al.. (1990). Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy. Cancer. 65(8). 1867–1878. 157 indexed citations
7.
Jacquemier, Jocelyne, et al.. (1990). Breast-conserving Therapy for Macroscopically Multiple Cancers. Annals of Surgery. 212(1). 38–44. 156 indexed citations
8.
Guillet, Pierre, et al.. (1990). [Value of clinical tests in the diagnosis of breast cancer: report of 2,626 cases].. PubMed. 77(11). 1073–86. 1 indexed citations
9.
Jacquemier, Jocelyne, et al.. (1990). An assessment of extensive intraductal component as a risk factor for local recurrence after breast-conserving therapy. British Journal of Cancer. 61(6). 873–876. 84 indexed citations
10.
Romain, S, et al.. (1990). [Prognostic value of thymidine kinase in cancer of the breast].. PubMed. 77(10). 973–83. 9 indexed citations
11.
Kurtz, John M., R. Amalric, H Brandone, et al.. (1989). Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis. Cancer. 63(10). 1912–1917. 341 indexed citations
12.
Kurtz, John M., Jocelyne Jacquemier, J. Torhorst, et al.. (1989). Conservation therapy for breast cancers other than infiltrating ductal carcinoma. Cancer. 63(8). 1630–1635. 154 indexed citations
13.
Amalric, R, et al.. (1989). Local recurrence after breast-conserving surgery and radiotherapy.. PubMed. 55(6). 837–42. 144 indexed citations
14.
Kurtz, John M., R. Amalric, H Brandone, Y Aymé, & J M Spitalier. (1988). Contralateral breast cancer and other second malignancies in patients treated by breast-conserving therapy with radiation. International Journal of Radiation Oncology*Biology*Physics. 15(2). 277–284. 81 indexed citations
15.
Kurtz, John M., R Amalric, H Brandone, Y Aymé, & J M Spitalier. (1988). Results of wide excision for mammary recurrence after breast-conserving therapy. Cancer. 61(10). 1969–1972. 68 indexed citations
16.
Kurtz, John M., J M Spitalier, R. Amalric, et al.. (1988). Mammary recurrences in women younger than forty. International Journal of Radiation Oncology*Biology*Physics. 15(2). 271–276. 102 indexed citations
17.
Amalric, R., et al.. (1984). Radiation therapy after breast-conserving surgery for Stage I and II mammary carcinoma. Results of the Marseille experience 1961 to 1976.. PubMed. 160(4). 239–43. 3 indexed citations
18.
Brandone, H, et al.. (1978). [Curative conservative treatment of benign operable breast cancers (705 cases with a 5-year follow-up)].. PubMed. 44(5-6). 629–38. 1 indexed citations
19.
Amalric, R, R Clément, Francesca Santamaria, et al.. (1977). [Curative radiotherapy with hope of saving the breast in operable breast cancers 403 cases with 5-year survival].. PubMed. 63(2). 239–48. 6 indexed citations
20.
Aymé, Y, et al.. (1976). Radiothérapie curative à espérance conservatrice des cancers du sein opérables. 403 cas de 5 ans. Bulletin du Cancer. 63(2). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026